top of page
medical affairs outsourcing, pharma market solutions, pharmaceutical services and consulting, pharmaceutical validation, pharma supply chain management, marketing of pharmaceutical products, regulatory affairs pharmaceutical, preclinical research companies, pharma marketing solutions, global pharmaceutical company, aseptic filling process in pharma, biomarker analysis in clinical trials, biotech companies, patent and intellectual property, chemistry manufacturing and controls training, cleaning validation, cleaning verification in pharmaceutical industry, regulatory affairs cmc, clinical data management, clinical research organisations London, clinical research management system, clinical trial companies, clinical trials in the uk, consultancy pharmaceutical industry, consultant for pharmaceutical industry, consultant pharmaceutical, consultant regulatory affairs, consulting services pharmaceutical industry, continuous manufacturing in pharma, contract research organisations uk,

Market Access & Health Economics 

We have access to a broad network of clinicians, payors and other stakeholders across a variety of therapeutic areas globally. This gives us the ability to offer solutions from regional and national perspectives that are tailored to the needs of a particular development programme. Whether it is value proposition, a simulation of evidence or development of a communication strategy our integrated team consists of health economists, writers and analysts who are able to help navigate the increasingly complex pricing and reimbursement climate faced by the life sciences industry today.

Pricing & Reimbursement

  • Optimizing strategies to ensure sustainable access to your portfolio

  • Value demonstration, pricing and market access strategy

  • Opportunity and Landscape Assessments

  • Value proposition in key markets

Health Economics and Outcomes Research (HEOR)

  • Evidence generation support to drive patient access and uptake

  • Review of real-world evidence strategy, trial design and model validation

  • Cost-effectiveness and Budget-impact modelling support

  • Bespoke statistical analyses

  • Systematic review

"Value Added" Communication Strategies

    • Scientific Advice support (in parallel with regulatory support)

    • Customer communication support in a variety of formats including digital value propositions

    • Driving payor engagement by supporting the key message in defining clinical, economic and innovative messages for different payor types

    • Helping internal teams understand the requirements for formulary access by creating “well defined” communication strategies

pharmaceutical industry solutions, pharmaceutical marketing, pharmaceutical marketing companies, pharmaceutical medicine, pharmaceutical outsourcing, pharmaceutical production companies, pharmaceutical products, pharmaceutical projects, pharmaceutical quality management system, pharmaceutical quality system, pharmaceutical quality system elements, pharmaceutical regulatory, pharmaceutical regulatory affairs, pharmaceutical serialisation, pharmaceutical services and consulting, pharmaceutical services ltd, pharmaceutical solution industries, pharmaceutical solutions, pharmaceutical supply, pharmaceutical supply chain, pharmaceutical supply chain issues, pharmaceutical validation, pharmaceuticals in the us, pharmacology toxicology, pharmacovigilance service providers, pharmacovigilance technology, preclinical companies, preclinical discovery, preclinical research, preclinical research companies, preclinical toxicology, production in pharma industry, production in pharmaceutical industry

Let's Work Together

bottom of page